|
Recent Developments |
|
25-NOV-13
The board of the directors of Pfizer (`Pfizer India) and Wyeth (Wyeth India) in their respective meetings have approved a proposal to merge Wyeth India with Pfizer India.
25-NOV-13
Pfizer, the research-based pharmaceutical company, announced that the board of directors has approved the payment of interim dividend of Rs 360 equity share of Rs 10 each (3600%) to the shareholders of the company. The said interim dividend will be paid on... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 30-Sep-2009(6) | 31-Mar-2009 (12) | 31-Mar-2007 (12) | | Net sales | 2274.20 | 3826.60 | 2881.27 | | Other Income | 65.20 | 199.80 | 28.59 | | Total Income | 2339.40 | 4026.40 | 2909.87 | | Cost of goods sold | 1549.60 | 0.00 | 1869.20 | | OPBDIT | 789.80 | 4026.40 | 1040.67 | | PAT | 543.40 | 996.70 | 923.57 | | Gross Block | - | - | 755.40 | | Equity capital | 227.20 | 227.20 | 227.20 | | EPS (Rs.) | - | 43.87 | 40.65 | | DPS (Rs.) | - | - | 30.00 | | BV (Rs.) | - | - | 112.97 | | P/E range (x) | - | 7.93 - 11.60 | 10.82 - 16.48 | | Debt / Equity (x) | - | - | 0.01 | | Operating margin (% of OI) | 33.8 | 100.0 | 35.8 | | Net margin (% of OI) | 23.2 | 24.8 | 31.7 |
|
|
Detailed Financials
|
|
|
|
|
